Successful treatment of unresectable gallbladder cancer with low-dose paclitaxel as palliative chemotherapy after failure of gemcitabine and oral S-1: A case report-Reference-Cited by-同舟云学术

Successful treatment of unresectable gallbladder cancer with low-dose paclitaxel as palliative chemotherapy after failure of gemcitabine and oral S-1: A case report

Published:2012 Issue:6 Volume:4 Page:1281-1284
ISSN:1792-1074
Container-title:Oncology Letters
language:en
Short-container-title:

Author:

TAJIMA HIDEHIRO,OHTA TETSUO,SHINBASHI HIROYUKI,HIROSE ATSUSHI,TSUKADA TOMOYA,OKAMOTO KOICHI,NAKANUMA SHINICHI,SAKAI SEISHO,FURUKAWA HIROYUKI,MAKINO ISAMU,NAKAMURA KEISHI,HAYASHI HIRONORI,OYAMA KATSUNOBU,INOKUCHI MASAFUMI,NAKAGAWARA HISATOSHI,MIYASHITA TOMOHARU,FUJITA HIDETO,TAKAMURA HIROYUKI,NINOMIYA ITASU,KITAGAWA HIROHISA,FUSHIDA SACHIO,FUJIMURA TAKASHI,MOURI HISATSUGU,OHTSUBO KOUSHIRO

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinicopathologic significance of the delta-like ligand 4, vascular endothelial growth factor, and hypoxia-inducible factor-2α in gallbladder cancer;Journal of Pathology and Translational Medicine;2023-03-15

2. Nab-paclitaxel: An effective third-line chemotherapy in patients with advanced, unresectable gallbladder cancer;Indian Journal of Medical Research;2020

3. Phase I study of third-line palliative chemotherapy with low dose paclitaxel for pancreatic cancer;Molecular and Clinical Oncology;2018-02-20

4. Phase I study of weekly palliative chemotherapy with low-dose third-line paclitaxel for biliary tract cancer;Molecular and Clinical Oncology;2017-03-30

5. Rapamycin and WYE-354 suppress human gallbladder cancer xenografts in mice;Oncotarget;2015-09-11